DSM appoints new Chief Technology Officer
Royal DSM announced that Marcel Wubbolts, currently Vice President R&D DSM Innovation Center, will assume the position of Chief Technology Officer for DSM as of October 1, reporting to Rob van Leen, Chief Innovation Officer.
Marcel Wubbolts
Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent Professor at the ETH in Zürich. He joined DSM as a senior scientist and became Managing Director of DSM Biotech GmbH, in Jülich, Germany. Thereafter, he was Competence Manager Biocatalysis & Biotransformations and then became Program Director at the DSM Innovation Center in Delft, the Netherlands, running the Industrial (White) Biotechnology program. Since January 2011 he is at his current position.
Marcel has published over 80 publications and patents in the area of biocatalysis and metabolic engineering. He serves on the board of the WG Applied Biocatalysis of the Dutch Society for Biotechnology (NBV); the board of the European Federation of Biotechnology Section on Applied Biocatalysis (ESAB); the Industrial Biotechnology council of EuropaBio; the supervisory board of ERA-NET Industrial Biotechnology and leads the Industrial Biotechnology Section of Suschem, European Technology Platform for Sustainable Chemistry.
Marcel will succeed Jos Put who will continue to be an advisor to DSM e.g. in the field of material sciences and for several of the DSM Science and Technology awards.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
